Expression of SV2 isoforms during rodent brain development

Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice

(2012) Kumar Venkatesan et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma

(2011) M. de Groot et al.   NEUROLOGY

Cotrafficking of SV2 and Synaptotagmin at the Synapse

(2010) J. Yao et al.   JOURNAL OF NEUROSCIENCE

Signals to promote myelin formation and repair

(2010) Carla Taveggia et al.   Nature Reviews Neurology

SV2 Acts via Presynaptic Calcium to Regulate Neurotransmitter Release

(2010) Qun-Fang Wan et al.   NEURON

Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam

(2009) Rafal M. Kaminski et al.   EPILEPSIA

Down-regulation Synaptic Vesicle Protein 2A in the Anterior Temporal Neocortex of Patients with Intractable Epilepsy

(2009) Guibo Feng et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis

(2009) W.-P. Chang et al.   JOURNAL OF NEUROSCIENCE

No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy

(2008) J.M. Lynch et al.   EPILEPSY RESEARCH

Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons

(2008) Min Dong et al.   MOLECULAR BIOLOGY OF THE CELL

SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy

(2007) Rafal M. Kaminski et al.   NEUROPHARMACOLOGY